Your search returned 50 studies. (Get alerts for new studies):
- Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
Conditions: Asthma
Location: Couer D'Alene, Idaho
- Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled
Conditions: COPD - COPD Exacerbation - Lung Diseases - Respiratory Disorders - Pulmonary Disease - Chronic Obstructive Lung Diseases - Chronic Obstructive Airway Disease
Location: Coeur d' Alene, Idaho
- Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
Conditions: Breast Cancer
Location: Coeur d'Alene, Idaho
- Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Conditions: Arthritis, Rheumatoid - Osteoarthritis
Location: Coeur D'Alene, Idaho
- Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Conditions: Arthritis, Rheumatoid - Osteoarthritis
Location: Spokane, Washington
- Using Alternative Implants for the Surgical Treatment of Hip Fractures (The FAITH Study)
Conditions: Femoral Neck Fractures
Location: Spokane, Washington
- Ankle Manual Therapy for Ankle Sprains
Conditions: Sprains and Strains
Location: Liberty Lake, Washington
- A Study to Evaluate New or Worsening Lens Opacifications in Subjects With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss Due to Andr
Conditions: Cancer - Cataract - Low Bone Mineral Density - Osteopenia - Osteoporosis - Prostate Cancer
Location: Coeur d'Alene, Idaho
- Phase II Randomized Trial Evaluating Neoadjuvant Therapy With Neratinib and/or Trastuzumab Followed by Postoperative Trastuzumab in Women With Locally
Conditions: Breast Cancer
Location: Post Falls, Idaho
- BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Conditions: Renal Cell Carcinoma
Location: Post Falls, Idaho
- Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy
Conditions: Leukaemia, Lymphocytic, Chronic
Location: Coeur d'Alene, Idaho
- Ofatumumab and Bendamustine Combination Therapy Compared With Bendamustine Monotherapy in Indolent B-cell Non-Hodgkin's Lymphoma (NHL) Unresponsive to
Conditions: Lymphoma, Follicular
Location: Coeur d'Alene, Idaho
- Efficacy & Safety Study of Oral Aripiprazole in Adolescents With Schizophrenia
Conditions: Schizophrenia
Location: Coeur D'Alene, Idaho
- A Study of Pemetrexed & Carboplatin/Cisplatin or Gemcitabine & Carboplatin/Cisplatin With or Without IMC-1121B in Patients Previously Untreate
Conditions: Carcinoma, Non-Small-Cell Lung
Location: Spokane, Washington
- Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary P
Conditions: Brenner Tumor - Ovarian Clear Cell Cystadenocarcinoma - Ovarian Endometrioid Adenocarcinoma - Ovarian Mixed Epithelial Carcinoma - Ovarian Mucinous Cystadenocarcinoma - Ovarian Serous Cystadenocarcinoma - Ovarian Undifferentiated Adenocarcinoma - Stage II
Location: Post Falls, Idaho
- A Study in Second Line Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
Location: Spokane, Washington
- A Study to Compare Subcutaneous Versus Intravenous Administration of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Active Rheuma
Conditions: Rheumatoid Arthritis
Location: Coeur D'alene, Idaho
- A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107 AM1)
Conditions: Arthritis, Rheumatoid
Location: Coeur d'Alene, Idaho
- A Study Of Inotuzumab Ozogamicin Plus Rituximab For Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma Patients Who Are Not Candidates For Intensive
Conditions: Lymphoma, Non-Hodgkin
Location: Coeur d' Alene, Idaho
- A Study Of Inotuzumab Ozogamicin Plus Rituximab For Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma Patients Who Are Not Candidates For Intensive
Conditions: Lymphoma, Non-Hodgkin
Location: Post Falls, Idaho
- Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder {P06107 Has an Extension (P05898; NCT01349907)}(P06107 AM4)
Conditions: Bipolar Disorder, Pediatric
Location: Coeur d'Alene, Idaho
- Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
Conditions: Estrogen Receptor-negative Breast Cancer - Estrogen Receptor-positive Breast Cancer - HER2-positive Breast Cancer - Progesterone Receptor-negative Breast Cancer - Progesterone Receptor-positive Breast Cancer - Recurrent Breast Cancer - Stage IA Breast Can
Location: Post Falls, Idaho
- A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Re
Conditions: Prostate Cancer Metastatic
Location: Coeur d'Alene, Idaho
- Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
Conditions: Atherosclerosis
Location: Coeur D Alene, Idaho
- A Study of RoActemra/Actemra (Tocilizumab) in Comparison to Etanercept in Patients With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors
Conditions: Cardiovascular Disease, Rheumatoid Arthritis
Location: Coeur D'alene, Idaho
- A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With MabThera/Rituxan (Rituximab) Plus Chemotherapy Followed by GA101 or MabThera/
Conditions: Non-Hodgkin's Lymphoma
Location: Post Falls, Idaho
- Efficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy up to 1 Year of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthritis
Conditions: Rheumatoid Arthritis
Location: Coeur d'Alene, Idaho
- A Study of Avastin (Bevacizumab) in Combination With Standard of Care Treatment in Patients With Lung Cancer
Conditions: Non-Small Cell Lung Cancer
Location: Post Falls, Idaho
- A Study of Pertuzumab in Addition to Chemotherapy and Herceptin (Trastuzumab) as Adjuvant Therapy in Patients With HER2-Positive Primary Breast Cancer
Conditions: Breast Cancer
Location: Post Falls, Idaho
- A Study of RO5072759 (GA101) in Combination With CHOP Chemotherapy in Patients With Previously Untreated Advanced Diffuse Large B-Cell Lymphoma (GATHE
Conditions: Lymphoma, B-Cell
Location: Coeur D'alene, Idaho
- A Trial of TH-302 in Combination With Doxorubicin Versus Doxorubicin Alone to Treat Patients With Locally Advanced Unresectable or Metastatic Soft Tis
Conditions: Soft Tissue Sarcoma
Location: Coeur d`Alene, Idaho
- Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
Conditions: Acute Lymphoid Leukemia - Acute Myeloid Leukemia - Chronic Lymphocytic Leukemia - Multiple Myeloma - Solid Tumors
Location: Spokane Valley, Washington
- A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3)
Conditions: Asthma
Location: Coeur d' Alene, Idaho
- NBRST: Prospective Neo-adjuvant REGISTRY Trial
Conditions: Breast Cancer
Location: Spokane, Washington
- Tolerability and Pharmacokinetics of Iloperidone in Adolescent Patients
Conditions: Safety and Tolerability of Iloperidone
Location: Coeur d'Alene, Idaho
- Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma
Conditions: Liposarcoma - Surgically Unresectable Liposarcoma - Metastatic Liposarcoma
Location: Post Falls, Idaho
- Caris Biorepository Research Protocol
Conditions: Cancer
Location: Couer D'Alene, Idaho
- Irritable Bowel Syndrome With Diarrhea (IBS-D) Rifaximin Re-Treatment Study
Conditions: Irritable Bowel Syndrome With Diarrhea
Location: Hayden Lake, Idaho
- Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
Conditions: Breast Cancer
Location: Post Falls, Idaho
- Prospective Registry Of MammaPrint in Patients With an Intermediate Recurrence Score
Conditions: Hormone Receptor Positive Malignant Neoplasm of Breast
Location: Spokane, Washington
- Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate/Vilanterol (FF/VI) Inhalation Powder 100/25mcg Once Daily Compared Wit
Conditions: Pulmonary Disease, Chronic Obstructive
Location: Coeur D'Alene, Idaho
- Study to Evaluate the Long Term Efficacy, Safety and Tolerability of Secukinumab in Patients With Rheumatoid Arthritis
Conditions: Rheumatoid Arthritis
Location: Coeur d'Alene, Idaho
- The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s)
Conditions: Coronary Artery Disease
Location: Coeur D'Alene, Idaho
- An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolesc
Conditions: Asthma
Location: Coeur D'Alene, Idaho
- Long Term Safety Study of NVA237 vs QAB149 in COPD Patients
Conditions: Chronic Obstructive Pulmonary Disease (COPD)
Location: Couer D'Alene, Idaho
- Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk
Conditions: Dyslipidemia
Location: Coeur D'Alene, Idaho
- Safety Study of PRTX-100 With Methotrexate or Leflunomide to Treat Active Rheumatoid Arthritis
Conditions: Arthritis, Rheumatoid
Location: Coeur d'Alene, Idaho
- Efficacy and Safety of the Addition of Fluticasone Propionate/Salmeterol (250/50mcg) Twice-daily to 2 Doses of Umeclidinium Bromide Inhalation Powder
Conditions: Pulmonary Disease, Chronic Obstructive
Location: Coeur D'Alene, Idaho
- The Inland Northwest Colon Cancer Survivor's Study
Conditions: Colon Cancer
Location: Spokane, Washington
- The Purpose of This Study is to Evaluate the Spirometric Effect (Trough FEV1) of Umeclidinium/Vilanterol 62.5/25 Mcg Once Daily Compared With Tiotriop
Conditions: Pulmonary Disease, Chronic Obstructive
Location: Coeur D'Alene, Idaho
|